scenesse / Scenesse (afamelanotide) for adults with a history of phototoxic reactions from

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / Disallow: /wp-content/plugins/ Disallow: /wp-admin/ Disallow: /readme.html Disallow: /refer/ Disallow: /bk/ Allow: /images/ Allow: /wp-content/uploads/ Sitemap:

Meta Tags

Title	Scenesse (afamelanotide) for adults with a history of phototoxic reactions from
Description	SCENESSE® SCENESSE® (afamelanotide) implant is the first FDA approved treatment to increase pain free light exposure in adult EPP
Keywords	N/A

Server Information

WebSite	scenesse.com
Host IP	64.207.159.230
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

scenesse.com Valuation

US$5,849,837

Last updated: 2023-05-18 02:12:35

scenesse.com has Semrush global rank of 1,809,333. scenesse.com has an estimated worth of US$ 5,849,837, based on its estimated Ads revenue. scenesse.com receives approximately 674,982 unique visitors each day. Its web server is located in United States, with IP address 64.207.159.230. According to SiteAdvisor, scenesse.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$5,849,837
Daily Ads Revenue	US$5,400
Monthly Ads Revenue	US$161,996
Yearly Ads Revenue	US$1,943,946
Daily Unique Visitors	44,999
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
scenesse.com.	A	40283	IP: 64.207.159.230
scenesse.com.	NS	21600	NS Record: ns2.mediatemple.net.
scenesse.com.	NS	21600	NS Record: ns1.mediatemple.net.
scenesse.com.	MX	21600	MX Record: 10 mail.scenesse.com.
scenesse.com.	TXT	21600	TXT Record: google-site-verification=Tx5ihy34-OfGrfqu4WlhJuvgLCIg5sJOxERAWhavpHo

HtmlToTextCheckTime:2023-05-18 02:12:35

Skip to the content This site is for US residents only Prescribing Information Important Safety Information Healthcare Professionals Login SCENESSE® (Afamelanotide) Menu About Erythropoietic Protoporphyria About SCENESSE® EPP Centers Savings Program Treatment Access FAQs Contact Us Close Menu Prescribing Information Important Safety Information Healthcare Professionals Login About Erythropoietic Protoporphyria About SCENESSE® EPP Centers Savings Program Treatment Access FAQs Contact Us SCENESSE® For adults with a history of phototoxic reactions from EPP SCENESSE ® (afamelanotide) implant is a prescription medication indicated to increase pain-free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP). SCENESSE ® is not right for everyone, and individual results may vary. Talk with your doctor to decide if SCENESSE ® may be right for you. To receive treatment, please visit: Savings Program – if you have commercial or private

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 06 May 2022 09:14:50 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://scenesse.com/

HTTP/2 200 
server: nginx
date: Fri, 06 May 2022 09:14:51 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-powered-by: PHP/7.4.29
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: User-Agent
x-powered-by: PleskLin

scenesse.com Whois Information

Domain Name: SCENESSE.COM
Registry Domain ID: 1570986943_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-08-23T16:01:46Z
Creation Date: 2009-10-02T03:33:32Z
Registry Expiry Date: 2022-10-02T03:33:32Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.MEDIATEMPLE.NET
Name Server: NS2.MEDIATEMPLE.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-06T10:51:18Z <<<

scenesse.com valuation and analysis